{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:12:31Z","timestamp":1791508351550,"version":"4.3.4"},"reference-count":47,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.3724\/abbs.2023259","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:53:10Z","timestamp":1699433590000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Valproic acid regulates the miR-155\/Jarid2 axis by                     affecting miR-155 promoter methylation in glioma"],"prefix":"10.3724","author":[{"given":"Ruixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuzhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"Stupp R","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K. Radiotherapy plus concomitant and adjuvant temozolomide for                         glioblastoma. N Engl J Med, 2005, 352: 987-996.","journal-title":"N Engl J Med"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"CMO.S390","DOI":"10.4137\/cmo.s390","volume":"2","author":"Komotar RJ","year":"2008","unstructured":"Komotar RJ, Otten ML, Moise G, Connolly Jr ES. Radiotherapy plus concomitant and adjuvant temozolomide for                         glioblastoma\u2014a critical review. Clin Med Oncol, 2008, 2:","journal-title":"Clin Med Oncol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"Louis DN","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H. The 2016 world health organization classification of tumors of                         the central nervous system: a summary. Acta Neuropathol, 2016, 131: 803-820.","journal-title":"Acta Neuropathol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"Louis DN","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW. The 2007 WHO classification of tumours of the central nervous                         system. Acta Neuropathol, 2007, 114: 97-109.","journal-title":"Acta Neuropathol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/157489210791760526","volume":"5","author":"Bei R","year":"2010","unstructured":"Bei R, Marzocchella L, Turriziani M. The use of temozolomide for the treatment of malignant tumors:                         clinical evidence and molecular mechanisms of action. Recent Pat                             Anticancer Drug Discov, 2010, 5: 172-187.","journal-title":"Recent Pat                             Anticancer Drug Discov"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14740330902918281","volume":"8","author":"Trinh VA","year":"2009","unstructured":"Trinh VA, Patel SP, Hwu WJ. The safety of temozolomide in the treatment of malignancies. Expert Opin Drug                             Saf, 2009, 8: 493-499.","journal-title":"Expert Opin Drug                             Saf"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.drudis.2015.02.011","volume":"20","author":"Messaoudi K","year":"2015","unstructured":"Messaoudi K, Clavreul A, Lagarce F. Toward an effective strategy in glioblastoma treatment. Part I:                         resistance mechanisms and strategies to overcome resistance of glioblastoma                         to temozolomide. Drug Discov                             Today, 2015, 20: 899-905.","journal-title":"Drug Discov                             Today"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1586\/ern.10.32","volume":"10","author":"Chamberlain MC","year":"2010","unstructured":"Chamberlain MC. Temozolomide: therapeutic limitations in the treatment of adult                         high-grade gliomas. Expert Rev NeuroTher, 2010, 10: 1537-1544.","journal-title":"Expert Rev NeuroTher"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"39759","DOI":"10.1074\/jbc.M110.147504","volume":"285","author":"Oliva CR","year":"2010","unstructured":"Oliva CR, Nozell SE, Diers A, McClugage Iii SG, Sarkaria JN, Markert JM, Darley-Usmar VM. Acquisition of temozolomide chemoresistance in gliomas leads to                         remodeling of mitochondrial electron transport chain. J Biol Chem, 2010, 285: 39759-39767.","journal-title":"J Biol Chem"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13046-019-1287-8","volume":"38","author":"Wen Z","year":"2019","unstructured":"Wen Z, Zeng W, Chen Y, Li H, Wang J, Cheng Q, Yu J. Knockdown ATG4C inhibits gliomas progression and promotes                         temozolomide chemosensitivity by suppressing autophagic flux. J Exp Clin                             Cancer Res, 2019, 38:","journal-title":"J Exp Clin                             Cancer Res"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"BSR20170696","DOI":"10.1042\/BSR20170696","volume":"37","author":"Du P","year":"2017","unstructured":"Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G, Liao Y. LncRNA-XIST interacts with miR-29c to modulate                         the chemoresistance of glioma cell to TMZ through DNA mismatch repair                         pathway. Biosci Rep, 2017, 37:","journal-title":"Biosci Rep"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-016-0303-5","volume":"35","author":"Yan Y","year":"2016","unstructured":"Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z. Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin                             Cancer Res, 2016, 35:","journal-title":"J Exp Clin                             Cancer Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/15384047.2021.1942711","volume":"22","author":"Kuang W","year":"2021","unstructured":"Kuang W, Jiang W, Chen Y, Tian Y, Liu Z. The function and mechanism of the JARID2\/CCND1 axis in modulating                         glioma cell growth and sensitivity to temozolomide (TMZ). Cancer Biol                             Ther, 2021, 22: 392-403.","journal-title":"Cancer Biol                             Ther"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/TP.0b013e3181e913c2","volume":"90","author":"Anglicheau D","year":"2010","unstructured":"Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation, 2010, 90: 105-112.","journal-title":"Transplantation"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1373\/clinchem.2008.112805","volume":"55","author":"Bartels CL","year":"2009","unstructured":"Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem, 2009, 55: 623-631.","journal-title":"Clin Chem"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"Di Leva G","year":"2014","unstructured":"Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu                             Rev Pathol Mech Dis, 2014, 9: 287-314.","journal-title":"Annu                             Rev Pathol Mech Dis"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/PPO.0b013e318250c001","volume":"18","author":"Iorio MV","year":"2012","unstructured":"Iorio MV, Croce CM. Causes and consequences of mMicroRNA dysregulation. Cancer J, 2012, 18: 215-222.","journal-title":"Cancer J"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.molonc.2015.03.007","volume":"9","author":"Piwecka M","year":"2015","unstructured":"Piwecka M, Rolle K, Belter A, Barciszewska AM, \u017bywicki M, Michalak M, Nowak S. Comprehensive analysis of microRNA expression profile in                         malignant glioma tissues. Mol Oncol, 2015, 9: 1324-1340.","journal-title":"Mol Oncol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/path.4109","volume":"229","author":"Moore LM","year":"2013","unstructured":"Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG. Transcriptome and small RNA deep sequencing reveals deregulation                         of miRNA biogenesis in human glioma. J Pathol, 2013, 229: 449-459.","journal-title":"J Pathol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"687362","DOI":"10.3389\/fonc.2021.687362","volume":"11","author":"Han W","year":"2021","unstructured":"Han W, Guan W. Valproic acid: a promising therapeutic agent in glioma treatment. Front Oncol, 2021, 11:","journal-title":"Front Oncol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"096368972098187","DOI":"10.1177\/0963689720981878","volume":"29","author":"Han W","year":"2020","unstructured":"Han W, Yu F, Cao J, Dong B, Guan W, Shi J. Valproic acid enhanced apoptosis by promoting autophagy via                         Akt\/mTOR signaling in glioma. Cell Transplant, 2020, 29:","journal-title":"Cell Transplant"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/carcin\/bgz069","volume":"40","author":"Luo D","year":"2019","unstructured":"Luo D, Fraga-Lauhirat M, Millings J, Ho C, Villarreal EM, Fletchinger TC, Bonfiglio JV. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth                         in preclinical models through the inhibition of STAT3 phosphorylation. Carcinogenesis, 2019, 40: 1480-1491.","journal-title":"Carcinogenesis"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbrc.2012.04.050","volume":"421","author":"Ryu CH","year":"2012","unstructured":"Ryu CH, Park KY, Kim SM, Jeong CH, Woo JS, Hou Y, Jeun SS. Valproic acid enhances anti-tumor effect of mesenchymal stem cell                         mediated HSV-TK gene therapy in intracranial glioma. Biochem Biophys                             Res Commun, 2012, 421: 585-590.","journal-title":"Biochem Biophys                             Res Commun"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"D360","DOI":"10.1093\/nar\/gkx1144","volume":"46","author":"Tokar T","year":"2018","unstructured":"Tokar T, Pastrello C, Rossos AEM, Abovsky M, Hauschild AC, Tsay M, Lu R. mirDIP 4.1-integrative database of human microRNA target                         predictions. Nucleic Acids Res, 2018, 46: D360-D370.","journal-title":"Nucleic Acids Res"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Chen Y","year":"2019","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA                         targets. Nucleic Acids Res, 2019, 48: D127-D131.","journal-title":"Nucleic Acids Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"Agarwal V","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife, 2015, 4:","journal-title":"eLife"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gks1246","volume":"41","author":"Paraskevopoulou MD","year":"2013","unstructured":"Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM, Hatzigeorgiou AG. DIANA-LncBase: experimentally verified and computationally                         predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res, 2013, 41: D239-D245.","journal-title":"Nucleic Acids Res"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7028901","volume":"2019","author":"Liang X","year":"2019","unstructured":"Liang X, Xu C, Wang W, Li X. The DNMT1\/miR-34a axis is involved in the stemness of human                         osteosarcoma cells and derived stem-like cells. Stem Cells Int, 2019, 2019: 1-20.","journal-title":"Stem Cells Int"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10555-017-9724-7","volume":"37","author":"Bayraktar R","year":"2018","unstructured":"Bayraktar R, Van Roosbroeck K. miR-155 in cancer drug resistance and as target for miRNA-based                         therapeutics. Cancer                             Metastasis Rev, 2018, 37: 33-44.","journal-title":"Cancer                             Metastasis Rev"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","volume":"107","author":"Van Nifterik KA","year":"2012","unstructured":"Van Nifterik KA, Van den Berg J, Slotman BJ, Lafleur MVM, Sminia P, Stalpers LJA. Valproic acid sensitizes human glioma cells for temozolomide and                         \u03b3-radiation. J NeuroOncol, 2012, 107: 61-67.","journal-title":"J NeuroOncol"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12885-019-5843-6","volume":"19","author":"Chen JC","year":"2019","unstructured":"Chen JC, Lee IN, Huang C, Wu YP, Chung CY, Lee MH, Lin MHC. Valproic acid-induced amphiregulin secretion confers resistance                         to temozolomide treatment in human glioma cells. BMC Cancer, 2019, 19:","journal-title":"BMC Cancer"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00109-010-0707-1","volume":"89","author":"Chen CH","year":"2011","unstructured":"Chen CH, Chang YJ, Ku MSB, Chung KT, Yang JT. Enhancement of temozolomide-induced apoptosis by valproic acid in                         human glioma cell lines through redox regulation. J Mol Med, 2011, 89: 303-315.","journal-title":"J Mol Med"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"Lee SY","year":"2016","unstructured":"Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis, 2016, 3: 198-210.","journal-title":"Genes Dis"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1874467211205010102","volume":"5","author":"Zhang J","year":"2012","unstructured":"Zhang J, F.G. Stevens M, D. Bradshaw T. Temozolomide: mechanisms of action, repair and resistance. Curr Mol                             Pharmacol, 2012, 5: 102-114.","journal-title":"Curr Mol                             Pharmacol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"109696","DOI":"10.1016\/j.biopha.2019.109696","volume":"122","author":"Wu M","year":"2020","unstructured":"Wu M, Duan Q, Liu X, Zhang P, Fu Y, Zhang Z, Liu L. MiR-155-5p promotes oral cancer progression by targeting                         chromatin remodeling gene ARID2. Biomed                             Pharmacother, 2020, 122:","journal-title":"Biomed                             Pharmacother"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.2147\/OTT.S193097","volume":"12","author":"Li N","year":"2019","unstructured":"Li N, Cui T, Guo W, Wang D, Mao L. MiR-155-5p accelerates the metastasis of cervical cancer cell via                         targeting TP53INP1. Onco Targets Ther, 2019, 12: 3181-3196.","journal-title":"Onco Targets Ther"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fonc.2020.01415","volume":"10","author":"Pasculli B","year":"2020","unstructured":"Pasculli B, Barbano R, Fontana A, Biagini T, Di Viesti MP, Rendina M, Valori VM. Hsa-miR-155-5p up-regulation in breast cancer and its relevance                         for treatment with poly[ADP-ribose] polymerase 1 (PARP-1) inhibitors. Front Oncol, 2020, 10:","journal-title":"Front Oncol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/aging.103669","volume":"13","author":"Xu W","year":"2021","unstructured":"Xu W, Song C, Wang X, Li Y, Bai X, Liang X, Wu J. Downregulation of miR-155-5p enhances the anti-tumor effect of                         cetuximab on triple-negative breast cancer cells via inducing cell apoptosis                         and pyroptosis. Aging, 2021, 13: 228-240.","journal-title":"Aging"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2018.02.026","volume":"421","author":"Al-Haidari A","year":"2018","unstructured":"Al-Haidari A, Algaber A, Madhi R, Syk I, Thorlacius H. MiR-155-5p controls colon cancer cell migration via                         post-transcriptional regulation of human antigen R (HuR). Cancer Lett, 2018, 421: 145-151.","journal-title":"Cancer Lett"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/neuonc\/nox017","volume":"19","author":"Wu X","year":"2017","unstructured":"Wu X, Wang Y, Yu T, Nie E, Hu Q, Wu W, Zhi T. Blocking MIR155HG\/miR-155 axis inhibits mesenchymal transition in                         glioma. Neuro-Oncology, 2017, 19: 1195-1205.","journal-title":"Neuro-Oncology"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10072-018-3518-8","volume":"39","author":"Deshpande RP","year":"2018","unstructured":"Deshpande RP, Panigrahi M, Y.B.V.K. C, Babu PP. Profiling of microRNAs modulating cytomegalovirus infection in                         astrocytoma patients. Neurol Sci, 2018, 39: 1895-1902.","journal-title":"Neurol Sci"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ijo.2019.4810","volume":"55","author":"Milani R","year":"2019","unstructured":"Milani R, Brognara E, Fabbri E, Manicardi A, Corradini R, Finotti A, Gasparello J. Targeting miR\u2011155\u20115p and miR\u2011221\u20113p by peptide nucleic acids                         induces caspase\u20113 activation and apoptosis in temozolomide\u2011resistant T98G                         glioma cells. Int J Oncol, 2019, 55: 59-68.","journal-title":"Int J Oncol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","volume":"21","author":"Berendsen S","year":"2012","unstructured":"Berendsen S, Broekman M, Seute T, Snijders T, van Es C, de Vos F, Regli L. Valproic acid for the treatment of malignant gliomas: review of                         the preclinical rationale and published clinical results. Expert Opin                             Investal Drugs, 2012, 21: 1391-1415.","journal-title":"Expert Opin                             Investal Drugs"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s10571-020-00930-2","volume":"41","author":"Han W","year":"2021","unstructured":"Han W, Yu F, Wang R, Guan W, Zhi F. Valproic acid sensitizes glioma cells to luteolin through                         induction of apoptosis and autophagy via akt signaling. Cell Mol                             Neurobiol, 2021, 41: 1625-1634.","journal-title":"Cell Mol                             Neurobiol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijbiomac.2020.06.265","volume":"163","author":"de Campos Vidal B","year":"2020","unstructured":"de Campos Vidal B, Mello MLS. Sodium valproate (VPA) interactions with DNA and histones. Int J Biol                             Macromolecules, 2020, 163: 219-231.","journal-title":"Int J Biol                             Macromolecules"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1021\/acs.chemrestox.7b00171","volume":"30","author":"Wolters JEJ","year":"2017","unstructured":"Wolters JEJ, van Breda SGJ, Caiment F, Claessen SM, de Kok TMCM, Kleinjans JCS. Nuclear and mitochondrial DNA methylation patterns induced by                         valproic acid in human hepatocytes. Chem Res                             Toxicol, 2017, 30: 1847-1854.","journal-title":"Chem Res                             Toxicol"},{"key":"CITATION47","doi-asserted-by":"crossref","unstructured":"Veronezi GM, Felisbino MB, Gatti MS, Mello ML, Vidal BC. DNA                         methylation changes in valproic acid-treated HeLa cells as assessed by image                         analysis, immunofluorescence and vibrational microspectroscopy.                              PLoS One                                                  2017, 12: e0170740.","DOI":"10.1371\/journal.pone.0170740"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CE328FE9F8DA441FB6B21AD43B469229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023259","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CE328FE9F8DA441FB6B21AD43B469229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T05:45:57Z","timestamp":1706247957000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3724\/abbs.2023259","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}